Short answer
Gossamer Bio, Inc. (GOSS) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 8.01 (Other Events). Nasdaq minimum bid-price deficiency cured; continued listing on Nasdaq Global Select Market preserved.
Gossamer Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Nasdaq minimum bid-price deficiency cured; continued listing on Nasdaq Global Select Market preserved
- Compliance followed 1-for-80 reverse stock split effective September 10, 2026
- Split-adjusted trading began September 11, 2026, highlighting substantial prior share-price pressure
- Nasdaq’s minimum bid-price matter closed September 25, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Gossamer Bio, Inc. 8-K filings
Get the next GOSS 8-K as it lands
Follow GOSS for push alerts, or ask the research agent what this filing means.